Chronic PainMovePainFallNCT07889024
Multicomponent Exercise and Pain Science Education for Fall Prevention in Older Adults With Chronic Musculoskeletal Pain (MovePainFall)
A study testing MovePainFall multicomponent exercise programme and Pain science and fall-prevention education in people with Chronic Pain and Musculoskeletal Pain, run by Instituto Politécnico de Bragança at 1 site in Portugal.
Trial summary
Chronic musculoskeletal pain is common in older adults and is associated with reduced mobility, loss of function, poorer quality of life, fear of movement, fear of falling and a higher risk of falls. Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- Chronic Pain, Musculoskeletal Pain, Accidental Falls
- What is being tested?
- MovePainFall multicomponent exercise programme and Pain science and fall-prevention education
- Type of treatment
- Injection or infusion, Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 sitePortugal
- Study dates
- 2 Nov 2026to 5 Mar 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Who may be able to join
- Aged 65 years or over.
- Living in the community (not institutionalised).
- Chronic musculoskeletal pain lasting 3 months or more.
- Able to walk independently, with or without a walking aid.
- Able to understand and sign the informed consent form.
Who cannot join
- Significant neurological disease affecting mobility.
- Unstable cardiovascular or metabolic conditions.
- Severe cognitive impairment preventing understanding of instructions or safe participation.
- Any medical contraindication to safe exercise participation (a complementary medical opinion will be requested whenever necessary to confirm eligibility and safety).
- Concurrent participation in another supervised exercise programme.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Portugal1 site
School of Education, Universidade Politécnica de Bragança (+Idade +Saúde community programme)
Bragança, Campus de Santa Apolónia, 5300-253
António Miguel Monteiro, PhD, +351962970784, mmonteiro@unipb.pt
Rui Pedro Rocha Pires, BSc
About this study
Official title: MovePainFall - Multicomponent Exercise and Pain Science Education for Fall Prevention in Community-Dwelling Older Adults With Chronic Musculoskeletal Pain: A Pilot Randomised Controlled Feasibility Trial
Chronic musculoskeletal pain is common in older adults and is associated with reduced mobility, loss of function, poorer quality of life, fear of movement, fear of falling and a higher risk of falls. Exercise programmes are effective in preventing falls, but very few programmes combine fall-prevention exercise with pain self-management, including pain science education, for older people who live in the community and have both chronic pain and an increased risk of falling.
The goal of this pilot randomised controlled feasibility trial is to find out whether it is feasible, acceptable and safe to deliver a 12-week supervised group programme (MovePainFall) that combines multicomponent exercise with pain science and fall-prevention education, compared with a control group that maintains usual activities, in community-dwelling adults aged 65 years or over with chronic musculoskeletal pain (lasting 3 months or more).
Read more
The main questions it aims to answer are:
- Is it feasible to recruit, randomise, retain and engage participants (recruitment rate, eligibility, adherence, retention) and is the programme safe and acceptable?
- What are the preliminary effects of the programme on mobility, balance, lower-limb strength, dual-task performance, pain intensity and interference, fear of falling, fear of movement and quality of life?
Researchers will compare the MovePainFall group with the control group to estimate feasibility parameters and preliminary effect sizes that will inform the design and sample size of a future full-scale randomised controlled trial.
Participants in the MovePainFall group will:
- attend three supervised 60-minute group exercise sessions per week for 12 weeks (warm-up, strength and power, challenging balance, motor-cognitive dual-task training, functional gait and daily-living tasks, relaxation);
- attend one additional 30-45-minute group education session per week on pain neuroscience, pain self-management and fall prevention.
Participants in the control group will maintain their usual activities and routine health care and may be invited to attend the programme after the post-intervention assessment (waiting list).
All participants will be assessed by blinded assessors before randomisation and after the 12-week intervention period.
Read the detailed description
Background and rationale:
Chronic musculoskeletal pain is highly prevalent in older adults and is a major determinant of disability, functional decline and reduced health-related quality of life. Persistent pain is associated with lower physical activity, muscle weakness, impaired postural control, fear of movement and fear of falling, which together promote avoidance behaviours and increase the risk of falls. Structured exercise (e.g., the Otago Exercise Programme, multicomponent strength, balance and functional training) is effective in preventing falls in community-dwelling older adults, and pain science education combined with exercise is well accepted by older people with chronic pain. However, no protocol has yet been identified that systematically integrates fall-prevention multicomponent exercise with pain self-management, including pain science education, in community-dwelling adults aged 65 years or over who have both chronic musculoskeletal pain and an increased risk of falling. Dual-task (motor-cognitive) training is also included because chronic pain may amplify cognitive-motor interference during gait and balance.
Objectives:
General: to assess the feasibility, acceptability and safety of a multicomponent exercise programme combined with pain science education, compared with a control group, in community-dwelling older adults with chronic musculoskeletal pain, and to explore its preliminary effects on clinical and functional outcomes.
Specific: (1) to assess the feasibility of recruitment, randomisation, retention, adherence and safety; (2) to explore changes in functional mobility, balance, lower-limb function and fall-risk-related task performance; (3) to assess changes in pain intensity and interference, fear of falling, fear of movement and quality of life; (4) to produce preliminary effect size estimates to inform a future full-scale randomised controlled trial.
Design and setting:
Two-arm, parallel-group pilot randomised controlled feasibility trial, reported according to the CONSORT 2025 statement and the CONSORT extension for randomised pilot and feasibility trials. The intervention is delivered within the existing community programme +Idade +Saúde at the School of Education of the Universidade Politécnica de Bragança (UPB; formerly Instituto Politécnico de Bragança, IPB), Portugal, in the context of the LiveWell - Research Centre for Active Living and Wellbeing Internal Seed Project call (project title: ActiveAge-Fall: Exercise, Pain Management and Fall Prevention in Older Adults).
Sample size:
As a feasibility study, no formal power calculation was performed. A sample of 30-40 participants follows methodological recommendations for pilot and feasibility trials and will allow estimation of recruitment, adherence and retention rates and of the variability of clinical outcomes with sufficient precision to inform the sample size of a definitive trial.
Recruitment and baseline characterisation:
Participants are recruited through the +Idade +Saúde programme. After screening and written informed consent, baseline data are collected: sociodemographic data, clinical data (musculoskeletal diagnoses, pain duration and location, pain medication, comorbidities), anthropometry (weight, height, body mass index), body composition by bioimpedance (TANITA MC780P MA), habitual physical activity (IPAQ-SF, Portuguese version; used for characterisation only) and number of self-reported falls in the previous 12 months.
Randomisation and blinding:
After the baseline assessment, participants are individually randomised (1:1) using a simple computer-generated sequence (RStudio) held by an independent researcher, ensuring allocation concealment. Outcome assessors are blinded and are different from the instructors; data forms and databases are coded and randomisation codes remain concealed until database lock. Participants and instructors cannot be blinded.
Interventions:
Intervention group: 12-week supervised group programme with three 60-minute multicomponent exercise sessions per week (warm-up/joint mobility; progressive strength and power training organised in three 4-week mesocycles; challenging balance training; motor-cognitive dual-task training in three progressive phases; functional gait and activities-of-daily-living circuit; relaxation), designed according to the ICFSR international exercise recommendations for older adults (FITT parameters), plus one weekly 30-45-minute group session of pain science and fall-prevention education. Intensity is monitored with the Borg rating of perceived exertion (6-20) and repetitions in reserve; progression is individualised.
Control group: usual activities and routine care, without new supervised structured exercise; may be invited to attend the programme after the post-intervention assessment (waiting list).
Safety procedures: sessions delivered by physiotherapists/qualified professionals; attendance recorded at every session, with telephone contact after two consecutive absences; structured adverse event log; participants may stop any activity at any time.
Assessments:
Assessments are performed at baseline and immediately after the 12-week intervention by trained blinded assessors, using standardised protocols. Primary (feasibility) outcomes: recruitment, eligibility/consent, adherence, retention, adverse events and acceptability (PGIC and satisfaction questionnaire). Pre-specified feasibility success criteria: recruitment >=75% of target, mean adherence >=70% of sessions, retention >=80%, and no serious intervention-related adverse events, interpreted using a traffic-light (green/amber/red) approach for progression to a definitive trial. Exploratory clinical outcomes: TUG, TUG-DT and dual-task cost, 30-second Chair Stand Test, Mini-BESTest, isokinetic knee strength (HUMAC NORM, 60 and 180 deg/s), BPI-SF, Short FES-I, TSK-13 and WHOQOL-BREF.
Statistical analysis:
Analyses are performed in R (RStudio) according to a pre-defined plan, focusing on estimation rather than hypothesis testing. Feasibility outcomes are summarised descriptively (means/SD or medians/IQR; frequencies and percentages) with 95% confidence intervals for the main proportions. For clinical outcomes, within-group pre-post changes and exploratory between-group comparisons are estimated as mean differences with 95% confidence intervals and effect sizes, following the intention-to-treat principle whenever feasible, complemented by per-protocol analyses where relevant.
Ethics and data protection:
The study was approved by the Ethics Committee of the Universidade Politécnica de Bragança (opinion no. 2458328, 4 October 2026) and is conducted in accordance with the Declaration of Helsinki, the Oviedo Convention and the General Data Protection Regulation (GDPR). Participants are identified by numerical codes; data are stored in password-protected files accessible only to the research team. No financial rewards are given to participants.
Funding:
LiveWell - Research Centre for Active Living and Wellbeing, Internal Call for LiveWell's Seed Projects, Universidade Politécnica de Bragança (process no. P574305-R733916-D2398889).
- Conditions
- Chronic Pain, Musculoskeletal Pain, Accidental Falls, Fear of Falling
- Being tested
- MovePainFall multicomponent exercise programme, Pain science and fall-prevention education
- Keywords
- Aged, Older Adults, Community-Dwelling, Exercise Therapy, Multicomponent Exercise, Resistance Training, Postural Balance, Dual-Task Training, Pain Neuroscience Education, Pain Self-Management, Fall Prevention, Kinesiophobia, Physiotherapy, Feasibility Studies, Pilot Randomised Controlled Trial
- Medical subject headings
- Chronic Pain, Musculoskeletal Pain, Kinesiophobia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
MovePainFall multicomponent exercise programmeBehavioural
Supervised group multicomponent exercise, 3 sessions/week x 60 min for 12 weeks (36 sessions), based on ICFSR exercise recommendations (FITT), Otago principles and MultiMove motor-cognitive training. Each session: (i) warm-up/joint mobility, 5-10 min, Borg 9-11; (ii) strength and power, 15 min, 4-6 functional exercises, 1-3 sets x 8-12 reps, from 30-40% to 70-80% 1RM (Borg 12-13 to 15-17), with power training (40-60% 1RM, maximal intended concentric velocity) in weeks 9-12; (iii) challenging balance, 10-15 min, stations with reduced base of support, weight shifts, reduced sensory input and stepping strategies; (iv) motor-cognitive dual-task training, 10 min, 3 phases of increasing complexity (weeks 1-4, 5-8, 9-12); (v) functional gait and ADL circuit, 10 min, Borg 12-14; (vi) relaxation, 5-10 min, Borg <11. Individualised progression; attendance and adverse events are recorded.
Pain science and fall-prevention educationBehavioural
Group education session of 30-45 minutes once per week for 12 weeks (12 sessions), delivered in addition to the exercise sessions and always combined with exercise. Pain neuroscience content: neurophysiology of pain, nociception, pain versus tissue damage, peripheral and central sensitisation, neuroplasticity, fear-avoidance, pain and sleep, cognitions (catastrophising, fear, self-efficacy) and emotions, and self-management strategies (exercise, activity pacing, sleep hygiene, stress management). Fall-prevention content: intrinsic and environmental risk factors, the role of strength and balance exercise, safe gait and transfers, managing fear of falling and active-living strategies. Delivered with discussion of personal experiences, metaphors, diagrams, audiovisual and written materials, and information leaflets.
| Study group | Role | What they receive |
|---|---|---|
| MovePainFall programme (multicomponent exercise + pain science education). | Experimental | Supervised group programme delivered by physiotherapists/qualified professionals within the community programme +Idade +Saúde (Polytechnic University of Bragança) for 12 weeks: three 60-minute multicomponent exercise sessions per week (warm-up and joint mobility; progressive strength and power training; challenging static and dynamic balance training; motor-cognitive dual-task training in 3 progressive phases; functional gait and activities-of-daily-living circuit; relaxation), plus one additional 30-45-minute group education session per week on pain neuroscience, pain self-management and fall prevention (12 sessions). Progression is individualised according to functional capacity, tolerance and symptom fluctuation. Receives: Behavioral: MovePainFall multicomponent exercise programme; Behavioral: Pain science and fall-prevention education |
| Control (usual activities) | No intervention | Participants maintain their usual daily activities and routine health care throughout the study and are asked not to start any new supervised structured exercise programme during the intervention period. Relevant changes in physical activity, treatments or interventions for musculoskeletal pain are recorded. They undergo the same assessments, at the same time points and with the same blinded assessors as the intervention group, and may be invited to attend the MovePainFall programme after the post-intervention assessment (waiting list). |
What is being measured
The primary outcome is the main question the study is designed to answer.
Recruitment rate
Number of participants recruited per month and proportion of the target sample (30-40 participants) recruited within the planned recruitment period. Pre-specified feasibility success criterion: >=75% of the target sample recruited. Participant flow will be reported in a CONSORT 2025 flow diagram, adapted according to the CONSORT extension for pilot and feasibility trials.
Measured: Recruitment period (approximately 2 weeks, before randomisation)
Eligibility and consent rates
Proportion of screened individuals who are eligible, and proportion of eligible individuals who consent to participate and are randomised (%, with 95% confidence intervals). Reasons for ineligibility and refusal will be recorded.
Measured: Recruitment period (approximately 2 weeks, before randomisation)
Adherence to the intervention
Percentage of scheduled sessions attended (36 exercise sessions and 12 education sessions), per participant and overall, in the intervention group. Pre-specified feasibility success criterion: mean attendance >=70% of sessions.
Measured: During the 12-week intervention period
Retention
Proportion of randomised participants who complete the post-intervention assessment, and proportion of dropouts with reasons, in each group. Pre-specified feasibility success criterion: retention >=80%.
Measured: From randomisation to post-intervention assessment (approximately 16 weeks, including a 2-week holiday break)
Safety: adverse events
Number, type and severity of adverse events, reported as counts and rates per participant and per session, recorded in a structured safety log. Pre-specified success criterion: no serious intervention-related adverse events.
Measured: From the start of the intervention to post-intervention assessment (approximately 16 weeks)
Acceptability: Patient Global Impression of Change (PGIC)
Participant-rated global impression of change in pain and function attributable to the exercise programme on the 7-point PGIC (Portuguese version; 1 = no change/worse to 7 = a great deal better), complemented by a brief study-specific satisfaction and acceptability questionnaire on the programme components.
Measured: Post-intervention (within 2 weeks after completion of the 12-week intervention)
Secondary outcomes (10)
Change in functional mobility: Timed Up and Go (TUG)
Time (seconds) to rise from a chair, walk 3 m, turn 180 degrees, walk back and sit down. Lower values indicate better mobility.
Measured: Baseline (before randomisation) and post-intervention (within 2 weeks after completion of the 12-week intervention)
Change in dual-task mobility: TUG with cognitive task (TUG-DT) and dual-task cost
TUG performed while serially subtracting 3 from a 3-digit number between 300 and 400 (seconds). Dual-task cost (%) = [(TUG-DT - TUG single task) / TUG single task] x 100; higher positive values indicate greater cognitive-motor interference.
Measured: Baseline (before randomisation) and post-intervention (within 2 weeks after completion of the 12-week intervention)
Change in lower-limb function: 30-second Chair Stand Test
Number of complete sit-to-stand repetitions in 30 seconds. Higher values indicate better lower-limb function.
Measured: Baseline (before randomisation) and post-intervention (within 2 weeks after completion of the 12-week intervention)
Change in balance: Mini-BESTest
European Portuguese Mini-BESTest, 14 items (anticipatory postural adjustments, reactive postural control, sensory orientation, dynamic gait), total score 0-28. Higher scores indicate better balance.
Measured: Baseline (before randomisation) and post-intervention (within 2 weeks after completion of the 12-week intervention)
Change in knee extensor and flexor muscle strength (isokinetic dynamometry)
Concentric peak torque (Nm), peak torque normalised to body mass (Nm/kg) and flexor/extensor ratio of the knee extensors and flexors at 60 deg/s and 180 deg/s, measured with a HUMAC NORM isokinetic dynamometer (CSMi).
Measured: Baseline (before randomisation) and post-intervention (within 2 weeks after completion of the 12-week intervention)
Change in pain intensity: Brief Pain Inventory - Short Form (BPI-SF)
Portuguese BPI-SF pain severity score: mean of 4 items (worst, least, average and current pain), each rated 0-10. Higher scores indicate more severe pain.
Measured: Baseline (before randomisation) and post-intervention (within 2 weeks after completion of the 12-week intervention)
Change in pain interference: Brief Pain Inventory - Short Form (BPI-SF)
Portuguese BPI-SF pain interference score: mean of 7 items (general activity, mood, walking, normal work, relations with others, sleep, enjoyment of life), each rated 0-10. Higher scores indicate greater interference.
Measured: Baseline (before randomisation) and post-intervention (within 2 weeks after completion of the 12-week intervention)
Change in fear of falling: Short Falls Efficacy Scale-International (Short FES-I)
European Portuguese Short FES-I, 7 items rated 1-4, total score 7-28. Higher scores indicate greater concern about falling.
Measured: Baseline (before randomisation) and post-intervention (within 2 weeks after completion of the 12-week intervention)
Change in kinesiophobia: Tampa Scale for Kinesiophobia (TSK-13)
Portuguese 13-item TSK, each item rated on a 4-point Likert scale, total score 13-52. Higher scores indicate greater fear of movement/(re)injury.
Measured: Baseline (before randomisation) and post-intervention (within 2 weeks after completion of the 12-week intervention)
Change in health-related quality of life: WHOQOL-BREF
European Portuguese WHOQOL-BREF, 26 items rated on 5-point Likert scales; scores for the physical, psychological, social relationships and environment domains and 2 general items. Higher scores indicate better perceived quality of life.
Measured: Baseline (before randomisation) and post-intervention (within 2 weeks after completion of the 12-week intervention)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Oct 2026
- Study start2 Nov 2026 (estimated)
- Primary completion5 Mar 2027 (estimated)
- Study completion5 Mar 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chronic PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Two-arm, parallel-group pilot randomised controlled feasibility trial. After baseline assessment, participants are individually randomised (1:1) to the MovePainFall intervention group or to a usual-activities control group, using a simple computer-generated random sequence (RStudio) held by an independent researcher who is not involved in recruitment, assessment or delivery of the intervention (concealed allocation). Control participants may be invited to attend the MovePainFall programme after the post-intervention assessment (waiting-list approach).
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Instituto Politécnico de Bragança
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Marisa Filipa dos Santos Lages, Instituto Politécnico de Bragança
- Investigators
- Marisa Filipa dos Santos Lages, Principal investigator, Universidade Politécnica de Bragança
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07889024
- Sponsor's protocol ID
- P576700-R735654-D2458328
- Other IDs
- P574305-R733916-D2398889
- Acronym
- MovePainFall
- Status last verified
- Oct 2026
- First submitted
- 14 Oct 2026
- Last updated
- 22 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: De-identified (anonymised) individual participant data underlying the results reported in publications (baseline characteristics, feasibility indicators and clinical outcomes), with the data dictionary, will be deposited in the institutional repository of the Polytechnic University of Bragança, in line with the study Data Management Plan, FAIR principles, GDPR and LiveWell guidelines, safeguarding participant confidentiality and the ethical and legal restrictions on sharing health data.
Study at a glance
From the registry record, last updated by the sponsor on 22 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- MovePainFall - Multicomponent Exercise and Pain Science Education for Fall Prevention in Community-Dwelling Older Adults With Chronic Musculoskeletal Pain: A Pilot Randomised Controlled Feasibility Trial
- ClinicalTrials.gov ID
- NCT07889024
- Acronym / sponsor ID
- MovePainFall / P576700-R735654-D2458328
- Conditions
- Chronic Pain, Musculoskeletal Pain, Accidental Falls, Fear of Falling
- Keywords
- Aged, Older Adults, Community-Dwelling, Exercise Therapy, Multicomponent Exercise, Resistance Training, Postural Balance, Dual-Task Training
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- Instituto Politécnico de BragançaUniversity, hospital or other
- Study start
- 2 Nov 2026 (estimated)
- Primary completion
- 5 Mar 2027 (estimated)
- Study completion
- 5 Mar 2027 (estimated)
- First posted
- 22 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Chronic musculoskeletal pain is common in older adults and is associated with reduced mobility, loss of function, poorer quality of life, fear of movement, fear of falling and a higher risk of falls. Exercise programmes are effective in preventing falls, but very few programmes combine fall-prevention exercise with pain self-management, including pain science education, for older people who live in the community and have both chronic pain and an increased risk of falling.
The goal of this pilot randomised controlled feasibility trial is to find out whether it is feasible, acceptable and safe to deliver a 12-week supervised group programme (MovePainFall) that combines multicomponent exercise with pain science and fall-prevention education, compared with a control group that maintains usual activities, in community-dwelling adults aged 65 years or over with chronic musculoskeletal pain (lasting 3 months or more).
The main questions it aims to answer are:
- Is it feasible to recruit, randomise, retain and engage participants (recruitment rate, eligibility, adherence, retention) and is the programme safe and acceptable?
- What are the preliminary effects of the programme on mobility, balance, lower-limb strength, dual-task performance, pain intensity and interference, fear of falling, fear of movement and quality of life?
Researchers will compare the MovePainFall group with the control group to estimate feasibility parameters and preliminary effect sizes that will inform the design and sample size of a future full-scale randomised controlled trial.
Participants in the MovePainFall group will:
- attend three supervised 60-minute group exercise sessions per week for 12 weeks (warm-up, strength and power, challenging balance, motor-cognitive dual-task training, functional gait and daily-living tasks, relaxation);
- attend one additional 30-45-minute group education session per week on pain neuroscience, pain self-management and fall prevention.
Participants in the control group will maintain their usual activities and routine health care and may be invited to attend the programme after the post-intervention assessment (waiting list).
All participants will be assessed by blinded assessors before randomisation and after the 12-week intervention period.
Detailed description
Background and rationale:
Chronic musculoskeletal pain is highly prevalent in older adults and is a major determinant of disability, functional decline and reduced health-related quality of life. Persistent pain is associated with lower physical activity, muscle weakness, impaired postural control, fear of movement and fear of falling, which together promote avoidance behaviours and increase the risk of falls. Structured exercise (e.g., the Otago Exercise Programme, multicomponent strength, balance and functional training) is effective in preventing falls in community-dwelling older adults, and pain science education combined with exercise is well accepted by older people with chronic pain. However, no protocol has yet been identified that systematically integrates fall-prevention multicomponent exercise with pain self-management, including pain science education, in community-dwelling adults aged 65 years or over who have both chronic musculoskeletal pain and an increased risk of falling. Dual-task (motor-cognitive) training is also included because chronic pain may amplify cognitive-motor interference during gait and balance.
Objectives:
General: to assess the feasibility, acceptability and safety of a multicomponent exercise programme combined with pain science education, compared with a control group, in community-dwelling older adults with chronic musculoskeletal pain, and to explore its preliminary effects on clinical and functional outcomes.
Specific: (1) to assess the feasibility of recruitment, randomisation, retention, adherence and safety; (2) to explore changes in functional mobility, balance, lower-limb function and fall-risk-related task performance; (3) to assess changes in pain intensity and interference, fear of falling, fear of movement and quality of life; (4) to produce preliminary effect size estimates to inform a future full-scale randomised controlled trial.
Design and setting:
Two-arm, parallel-group pilot randomised controlled feasibility trial, reported according to the CONSORT 2025 statement and the CONSORT extension for randomised pilot and feasibility trials. The intervention is delivered within the existing community programme +Idade +Saúde at the School of Education of the Universidade Politécnica de Bragança (UPB; formerly Instituto Politécnico de Bragança, IPB), Portugal, in the context of the LiveWell - Research Centre for Active Living and Wellbeing Internal Seed Project call (project title: ActiveAge-Fall: Exercise, Pain Management and Fall Prevention in Older Adults).
Sample size:
As a feasibility study, no formal power calculation was performed. A sample of 30-40 participants follows methodological recommendations for pilot and feasibility trials and will allow estimation of recruitment, adherence and retention rates and of the variability of clinical outcomes with sufficient precision to inform the sample size of a definitive trial.
Recruitment and baseline characterisation:
Participants are recruited through the +Idade +Saúde programme. After screening and written informed consent, baseline data are collected: sociodemographic data, clinical data (musculoskeletal diagnoses, pain duration and location, pain medication, comorbidities), anthropometry (weight, height, body mass index), body composition by bioimpedance (TANITA MC780P MA), habitual physical activity (IPAQ-SF, Portuguese version; used for characterisation only) and number of self-reported falls in the previous 12 months.
Randomisation and blinding:
After the baseline assessment, participants are individually randomised (1:1) using a simple computer-generated sequence (RStudio) held by an independent researcher, ensuring allocation concealment. Outcome assessors are blinded and are different from the instructors; data forms and databases are coded and randomisation codes remain concealed until database lock. Participants and instructors cannot be blinded.
Interventions:
Intervention group: 12-week supervised group programme with three 60-minute multicomponent exercise sessions per week (warm-up/joint mobility; progressive strength and power training organised in three 4-week mesocycles; challenging balance training; motor-cognitive dual-task training in three progressive phases; functional gait and activities-of-daily-living circuit; relaxation), designed according to the ICFSR international exercise recommendations for older adults (FITT parameters), plus one weekly 30-45-minute group session of pain science and fall-prevention education. Intensity is monitored with the Borg rating of perceived exertion (6-20) and repetitions in reserve; progression is individualised.
Control group: usual activities and routine care, without new supervised structured exercise; may be invited to attend the programme after the post-intervention assessment (waiting list).
Safety procedures: sessions delivered by physiotherapists/qualified professionals; attendance recorded at every session, with telephone contact after two consecutive absences; structured adverse event log; participants may stop any activity at any time.
Assessments:
Assessments are performed at baseline and immediately after the 12-week intervention by trained blinded assessors, using standardised protocols. Primary (feasibility) outcomes: recruitment, eligibility/consent, adherence, retention, adverse events and acceptability (PGIC and satisfaction questionnaire). Pre-specified feasibility success criteria: recruitment >=75% of target, mean adherence >=70% of sessions, retention >=80%, and no serious intervention-related adverse events, interpreted using a traffic-light (green/amber/red) approach for progression to a definitive trial. Exploratory clinical outcomes: TUG, TUG-DT and dual-task cost, 30-second Chair Stand Test, Mini-BESTest, isokinetic knee strength (HUMAC NORM, 60 and 180 deg/s), BPI-SF, Short FES-I, TSK-13 and WHOQOL-BREF.
Statistical analysis:
Analyses are performed in R (RStudio) according to a pre-defined plan, focusing on estimation rather than hypothesis testing. Feasibility outcomes are summarised descriptively (means/SD or medians/IQR; frequencies and percentages) with 95% confidence intervals for the main proportions. For clinical outcomes, within-group pre-post changes and exploratory between-group comparisons are estimated as mean differences with 95% confidence intervals and effect sizes, following the intention-to-treat principle whenever feasible, complemented by per-protocol analyses where relevant.
Ethics and data protection:
The study was approved by the Ethics Committee of the Universidade Politécnica de Bragança (opinion no. 2458328, 4 October 2026) and is conducted in accordance with the Declaration of Helsinki, the Oviedo Convention and the General Data Protection Regulation (GDPR). Participants are identified by numerical codes; data are stored in password-protected files accessible only to the research team. No financial rewards are given to participants.
Funding:
LiveWell - Research Centre for Active Living and Wellbeing, Internal Call for LiveWell's Seed Projects, Universidade Politécnica de Bragança (process no. P574305-R733916-D2398889).
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Two-arm, parallel-group pilot randomised controlled feasibility trial. After baseline assessment, participants are individually randomised (1:1) to the MovePainFall intervention group or to a usual-activities control group, using a simple computer-generated random sequence (RStudio) held by an independent researcher who is not involved in recruitment, assessment or delivery of the intervention (concealed allocation). Control participants may be invited to attend the MovePainFall programme after the post-intervention assessment (waiting-list approach).
| Arm | Type | Receives |
|---|---|---|
| MovePainFall programme (multicomponent exercise + pain science education). | Experimental | Behavioral: MovePainFall multicomponent exercise programme, Behavioral: Pain science and fall-prevention educationSupervised group programme delivered by physiotherapists/qualified professionals within the community programme +Idade +Saúde (Polytechnic University of Bragança) for 12 weeks: three 60-minute multicomponent exercise sessions per week (warm-up and joint mobility; progressive strength and power training; challenging static and dynamic balance training; motor-cognitive dual-task training in 3 progressive phases; functional gait and activities-of-daily-living circuit; relaxation), plus one additional 30-45-minute group education session per week on pain neuroscience, pain self-management and fall prevention (12 sessions). Progression is individualised according to functional capacity, tolerance and symptom fluctuation. |
| Control (usual activities) | No intervention | –Participants maintain their usual daily activities and routine health care throughout the study and are asked not to start any new supervised structured exercise programme during the intervention period. Relevant changes in physical activity, treatments or interventions for musculoskeletal pain are recorded. They undergo the same assessments, at the same time points and with the same blinded assessors as the intervention group, and may be invited to attend the MovePainFall programme after the post-intervention assessment (waiting list). |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
Key inclusion criteria (5 listed)
- Aged 65 years or over.
- Living in the community (not institutionalised).
- Chronic musculoskeletal pain lasting 3 months or more.
- Able to walk independently, with or without a walking aid.
- Able to understand and sign the informed consent form.
Key exclusion criteria (5 listed)
- Significant neurological disease affecting mobility.
- Unstable cardiovascular or metabolic conditions.
- Severe cognitive impairment preventing understanding of instructions or safe participation.
- Any medical contraindication to safe exercise participation (a complementary medical opinion will be requested whenever necessary to confirm eligibility and safety).
- Concurrent participation in another supervised exercise programme.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| MovePainFall multicomponent exercise programmeSupervised group multicomponent exercise, 3 sessions/week x 60 min for 12 weeks (36 sessions), based on ICFSR exercise recommendations (FITT), Otago principles and MultiMove motor-cognitive training. Each session: (i) warm-up/joint mobility, 5-10 min, Borg 9-11; (ii) strength and power, 15 min, 4-6 functional exercises, 1-3 sets x 8-12 reps, from 30-40% to 70-80% 1RM (Borg 12-13 to 15-17), with power training (40-60% 1RM, maximal intended concentric velocity) in weeks 9-12; (iii) challenging balance, 10-15 min, stations with reduced base of support, weight shifts, reduced sensory input and stepping strategies; (iv) motor-cognitive dual-task training, 10 min, 3 phases of increasing complexity (weeks 1-4, 5-8, 9-12); (v) functional gait and ADL circuit, 10 min, Borg 12-14; (vi) relaxation, 5-10 min, Borg <11. Individualised progression; attendance and adverse events are recorded. | Behavioural | MovePainFall programme (multicomponent exercise + pain science education). |
| Pain science and fall-prevention educationGroup education session of 30-45 minutes once per week for 12 weeks (12 sessions), delivered in addition to the exercise sessions and always combined with exercise. Pain neuroscience content: neurophysiology of pain, nociception, pain versus tissue damage, peripheral and central sensitisation, neuroplasticity, fear-avoidance, pain and sleep, cognitions (catastrophising, fear, self-efficacy) and emotions, and self-management strategies (exercise, activity pacing, sleep hygiene, stress management). Fall-prevention content: intrinsic and environmental risk factors, the role of strength and balance exercise, safe gait and transfers, managing fear of falling and active-living strategies. Delivered with discussion of personal experiences, metaphors, diagrams, audiovisual and written materials, and information leaflets. | Behavioural | MovePainFall programme (multicomponent exercise + pain science education). |
Primary outcome
Recruitment rate
Time frame: Recruitment period (approximately 2 weeks, before randomisation)
Number of participants recruited per month and proportion of the target sample (30-40 participants) recruited within the planned recruitment period. Pre-specified feasibility success criterion: >=75% of the target sample recruited. Participant flow will be reported in a CONSORT 2025 flow diagram, adapted according to the CONSORT extension for pilot and feasibility trials.
Eligibility and consent rates
Time frame: Recruitment period (approximately 2 weeks, before randomisation)
Proportion of screened individuals who are eligible, and proportion of eligible individuals who consent to participate and are randomised (%, with 95% confidence intervals). Reasons for ineligibility and refusal will be recorded.
Adherence to the intervention
Time frame: During the 12-week intervention period
Percentage of scheduled sessions attended (36 exercise sessions and 12 education sessions), per participant and overall, in the intervention group. Pre-specified feasibility success criterion: mean attendance >=70% of sessions.
Retention
Time frame: From randomisation to post-intervention assessment (approximately 16 weeks, including a 2-week holiday break)
Proportion of randomised participants who complete the post-intervention assessment, and proportion of dropouts with reasons, in each group. Pre-specified feasibility success criterion: retention >=80%.
Safety: adverse events
Time frame: From the start of the intervention to post-intervention assessment (approximately 16 weeks)
Number, type and severity of adverse events, reported as counts and rates per participant and per session, recorded in a structured safety log. Pre-specified success criterion: no serious intervention-related adverse events.
Acceptability: Patient Global Impression of Change (PGIC)
Time frame: Post-intervention (within 2 weeks after completion of the 12-week intervention)
Participant-rated global impression of change in pain and function attributable to the exercise programme on the 7-point PGIC (Portuguese version; 1 = no change/worse to 7 = a great deal better), complemented by a brief study-specific satisfaction and acceptability questionnaire on the programme components.
10 secondary outcomes
Change in functional mobility: Timed Up and Go (TUG)
Time frame: Baseline (before randomisation) and post-intervention (within 2 weeks after completion of the 12-week intervention)
Change in dual-task mobility: TUG with cognitive task (TUG-DT) and dual-task cost
Time frame: Baseline (before randomisation) and post-intervention (within 2 weeks after completion of the 12-week intervention)
Change in lower-limb function: 30-second Chair Stand Test
Time frame: Baseline (before randomisation) and post-intervention (within 2 weeks after completion of the 12-week intervention)
Change in balance: Mini-BESTest
Time frame: Baseline (before randomisation) and post-intervention (within 2 weeks after completion of the 12-week intervention)
Change in knee extensor and flexor muscle strength (isokinetic dynamometry)
Time frame: Baseline (before randomisation) and post-intervention (within 2 weeks after completion of the 12-week intervention)
Change in pain intensity: Brief Pain Inventory - Short Form (BPI-SF)
Time frame: Baseline (before randomisation) and post-intervention (within 2 weeks after completion of the 12-week intervention)
Change in pain interference: Brief Pain Inventory - Short Form (BPI-SF)
Time frame: Baseline (before randomisation) and post-intervention (within 2 weeks after completion of the 12-week intervention)
Change in fear of falling: Short Falls Efficacy Scale-International (Short FES-I)
Time frame: Baseline (before randomisation) and post-intervention (within 2 weeks after completion of the 12-week intervention)
Change in kinesiophobia: Tampa Scale for Kinesiophobia (TSK-13)
Time frame: Baseline (before randomisation) and post-intervention (within 2 weeks after completion of the 12-week intervention)
Change in health-related quality of life: WHOQOL-BREF
Time frame: Baseline (before randomisation) and post-intervention (within 2 weeks after completion of the 12-week intervention)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Oct 2026.
- Individual participant dataSharing planned: Yes. De-identified (anonymised) individual participant data underlying the results reported in publications (baseline characteristics, feasibility indicators and clinical outcomes), with the data dictionary, will be deposited in the institutional repository of the Polytechnic University of Bragança, in line with the study Data Management Plan, FAIR principles, GDPR and LiveWell guidelines, safeguarding participant confidentiality and the ethical and legal restrictions on sharing health data.
Related trials for Chronic Pain
Not yet recruiting
Effects of Adding Vagal Neuromodulation to Manual Therapy in Women With Fibromyalgia
Fibromyalgia (FM) OR Fibromyalgia Syndrome, Manuel Therapy
Not yet recruitingPhase 3
Veterans' Intervention Blending NeuRomodulation and YogA for Chronic Low BackPaiN Treatment: VIBRANT
Chronic Low Back Pain, Musculoskeletal Pain
Not yet recruitingPhase 2
Psilocybin-Assisted Physical Therapy in Chronic Low Back Pain
Chronic Low Back Pain (CLBP), Physical Therapy
Not yet recruiting
Effects of Music During Walking on Pain and Muscle Activation in People With Chronic Pain Due to Knee Osteoarthritis
Knee Osteoarthritis
Not yet recruitingPhase 2/3
PRP Versus NP Injections for Chronic Discogenic Low Back Pain
Discogenic Low Back Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Marisa Filipa dos Santos Lages principal investigator
Universidade Politécnica de Bragança
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing MovePainFall multicomponent exercise programme and Pain science and fall-prevention education in people with Chronic Pain and Musculoskeletal Pain, run by Instituto Politécnico de Bragança at 1 site in Portugal.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 22 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Marisa Filipa dos Santos Lages, PhD (+351919060230, marisalages@unipb.pt), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Recruitment rate (time frame: Recruitment period (approximately 2 weeks, before randomisation)). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Oct 2026.